Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company under Zydus Lifesciences, Ltd., has finalized an agreement with Cyprium Therapeutics, Inc., a subsidiary of Fortress Biotech, Inc. The deal involves the transfer of worldwide…
Business news around the world
Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company under Zydus Lifesciences, Ltd., has finalized an agreement with Cyprium Therapeutics, Inc., a subsidiary of Fortress Biotech, Inc. The deal involves the transfer of worldwide…